Echocardiography Devices Market Size 2024-2028 

The echocardiography (ECG) devices market size is forecast to increase by USD 5.27 billion at a CAGR of 6.78% between 2023 and 2028. The ECG devices market is witnessing significant growth due to the increased incidence of cardiac disorders worldwide. To cater to the growing demand, market participants are integrating advanced technologies such as artificial intelligence and machine learning to develop next-generation ECG devices. However, the high cost of ECG products and procedures remains a major challenge for both patients and healthcare providers, limiting the market's growth potential. Despite this, the market is expected to continue its expansion, driven by the increasing prevalence of cardiac disorders and the ongoing technological advancements in ECG devices.

 Request Free Sample

The global echocardiography market is experiencing significant growth due to the increasing prevalence of cardiovascular diseases such as blood clots, uncontrolled hypertension, and atrial fibrillation. Echocardiography, a noninvasive diagnostic procedure, uses ultrasonic sound waves to examine the heart's chambers, valves, and blood flow. Transthoracic and transesophageal echocardiography are the two main types, with the latter providing more detailed images. Stress cardiac ultrasound is another variation used to assess heart function during physical activity. Technological developments in echocardiography include the use of transducers that emit and receive ultrasound waves, enabling real-time imaging. The British Heart Foundation and other research institutions are continually investigating new applications for echocardiography, such as in the diagnosis and monitoring of heart conditions.

The Heart Center Leipzig and Saarland University Hospital are leading institutions in this field. General imaging companies, such as GE Healthcare and Philips, offer echocardiography systems, including the Ultrasound 3300, which prioritize efficiency and workflow optimization. Cardiovascular imaging plays a crucial role in the early detection and treatment of heart conditions, improving patient outcomes and reducing healthcare costs.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• End-user
  • Hospitals
  • Diagnostic centers
• Product
  • Resting
  • Ambulatory
  • Stress
• Geography
  • North America
    • US
  • Europe
    • Germany
  • Asia
  • Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period. The Echocardiography market holds significant growth potential due to the increasing prevalence of cardiovascular diseases, such as blood clots, heart valve disease, heart failure, pericardial disease, coronary heart disease, and heart arrhythmias, including atrial fibrillation. Echocardiography is a non-invasive diagnostic procedure that utilizes ultrasonic sound waves to assess heart function, measure heart chambers, and evaluate heart structures like valves. This technique is particularly beneficial in identifying conditions related to chest pain or symptoms indicative of heart diseases. Technological developments, including AI-driven auto-measure applications, have enhanced the efficiency of echocardiography devices. The market is segmented into Transthoracic Echocardiography (TTE), Transesophageal Echocardiography (TEE), Stress Echocardiography, and Doppler Imaging.

Further, notable echocardiography devices include Clarius Mobile Health's handheld ultrasound system, Ultrasound Workspace's Vivid Ultra Edition, and GE Healthcare's Ultrasound 3300. These devices offer advanced features like measurement uniformity, improved imaging quality, and user-friendly interfaces. The growing number of angioplasty surgeries and the need for non-invasive diagnostic procedures further fuel the demand for echocardiography devices. Institutes like Heart Center Leipzig are at the forefront of research and innovation in the field, contributing to the development of new echocardiography techniques and applications. The market is expected to witness continued growth due to the rising prevalence of uncontrolled hypertension and other heart-related disorders. Echocardiography's non-invasive nature, safety, and ability to provide real-time visualization make it an essential tool in cardiovascular imaging.

Get a glance at the market share of various segments Request Free Sample

The hospitals segment accounted for USD 7.34 billion in 2018 and showed a gradual increase during the forecast period.

Regional Insights

North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

Echocardiography (ECG) devices play a pivotal role in the diagnosis and management of cardiovascular diseases. To enhance the efficiency and accuracy of these diagnostic tools, workflow optimization is a critical aspect. Rapid diagnosis is essential to improve patient outcomes, and AI-driven technologies are revolutionizing the field. Neural network-based algorithms and advanced 2D echo imaging are key components of these solutions. They enable automated analysis of cardiac structures and functions, reducing diagnostic test time and increasing accuracy. These technologies streamline the diagnostic process, ensuring that healthcare professionals can make informed decisions based on reliable data. The integration of AI and advanced imaging techniques in ECG devices is transforming cardiovascular care, enabling faster, more accurate diagnoses and improving patient outcomes.

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Echocardiography (ECG) Devices Market Driver

Increased incidence of cardiac disorders is the key driver of the market. The Echocardiography market is witnessing significant growth due to the increasing prevalence of cardiovascular diseases, such as heart failure, heart valve disease, heart arrhythmias, pericardial disease, coronary heart disease, and atrial fibrillation. These heart conditions are often caused by uncontrolled hypertension, which is a major risk factor for heart diseases. Hypertension affects more than half a billion people worldwide, accounting for nearly a third of all global deaths in 2021. Echocardiography is a noninvasive diagnostic procedure that uses ultrasonic sound waves to visualize the heart's chambers, valves, and blood flow. Technological developments in echocardiography devices, such as AI-driven auto-measure applications, have improved measurement uniformity and efficiency.

The market is segmented into Transthoracic Echocardiography (TTE), Transesophageal Echocardiography (TEE), Stress Echocardiography, and Doppler Imaging. Key players in the market include Clarius Mobile Health, Ultrasound Workspace, and General Imaging. Notable echocardiography devices include the Vivid Ultra Edition from GE Healthcare, Ultrasound 3300 from Philips, and Cardiovascular Imaging from Siemens Healthineers. These devices provide accurate heart function assessment and are essential for diagnosing and monitoring various heart-related disorders. The market is driven by the increasing number of angioplasty surgeries and the growing demand for noninvasive diagnostic procedures. Furthermore, the development of advanced echocardiography systems, such as 3D and 4D echocardiography, is expected to boost market growth. The Heart Center Leipzig is a leading research center focusing on echocardiography technology and its applications in diagnosing and treating heart diseases.

Echocardiography (Ecg) Devices Market Trends

Integration of technologies to develop advanced ECG devices is the upcoming trend in the market. The Echocardiography market has experienced significant growth due to the increasing prevalence of cardiovascular diseases, such as heart valve disease, heart failure, pericardial disease, coronary heart disease, and heart arrhythmias, including atrial fibrillation. Echocardiography devices, including transthoracic, transesophageal, stress, and Doppler imaging, play a crucial role in diagnosing and monitoring these heart-related disorders. Technological developments, such as AI-driven auto-measure applications and ultrasound systems from companies like Clarius Mobile Health, Ultrasound Workspace, and GE Healthcare's Vivid Ultra Edition, have improved measurement uniformity and efficiency. These noninvasive diagnostic procedures are essential for identifying blood clots in the heart's chambers and assessing heart function.

Furthermore, the flexibility and portability of these systems, enabled by wireless data systems, have streamlined workflows and enhanced patient comfort. For instance, the Heart Center Leipzig has integrated advanced imaging technologies to provide more accurate diagnoses and personalized treatment plans for patients with uncontrolled hypertension, heart diseases, and angioplasty surgeries.

Echocardiography (Ecg) Devices Market Challenge

The high cost of ECG products and procedures is a key challenge affecting the market growth. The Echocardiography market is witnessing significant growth due to the increasing prevalence of cardiovascular diseases, including heart valve disease, heart failure, pericardial disease, coronary heart disease, atrial fibrillation, and heart arrhythmias. Echocardiography, a noninvasive diagnostic procedure, uses ultrasonic sound waves to assess the heart's chambers, blood clots, and valves. Technological developments, such as AI-driven auto-measure applications, have improved the efficiency and measurement uniformity of these devices. Transthoracic and transesophageal echocardiography are the most common types of procedures used for diagnosing heart-related disorders. Transducer technology and Doppler imaging have played a crucial role in the advancement of these devices. Companies like Clarius Mobile Health and Ultrasound Workspace are innovating with portable and handheld echocardiography devices to cater to the cost-sensitive market.

Despite the cost pressure on hospitals, diagnostic centers, and ASCs, advanced echocardiography devices, such as the Vivid Ultra Edition and Ultrasound 3300, continue to be popular among Tier-1 and Tier-2 hospitals due to their wide functions, including wireless, Bluetooth, data integration, and remote monitoring. However, the increasing prevalence of uncontrolled hypertension and the need for stress echocardiography for angioplasty surgeries are expected to boost the demand for these advanced devices.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

AliveCor Inc. - The company offers Echocardiography devices such as KardiaMobile which is medical grade personal ECG device application.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Allengers Medical Systems Ltd.
• Baxter International Inc.
• Bionet Co. Ltd.
• Biotricity Inc.
• Bittium Corp.
• Cardinal Health Inc.
• DMS Service LLC
• Fukuda Denshi Co. Ltd
• General Electric Co.
• Halma Plc
• iRhythm Technologies Inc.
• Johnson and Johnson Services Inc.
• Koninklijke Philips N.V.
• Medtronic Plc
• Nasiff Associates Inc.
• NEXUS LIFECARE PVT. LTD.
• Nihon Kohden Corp.
• Norav Medical
• OSI Systems Inc.
• SCHILLER AG
• QT Medical

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

The echocardiography market is witnessing significant growth due to the increasing prevalence of cardiovascular diseases, including heart diseases, heart valve disease, heart failure, pericardial disease, coronary heart disease, and heart arrhythmias such as atrial fibrillation. Echocardiography, a noninvasive diagnostic procedure, uses ultrasonic sound waves to assess heart function, blood flow, and the structure of the heart's chambers, valves, and blood vessels. Technological developments in echocardiography include AI-driven auto-measure applications, transducer technology, and advanced imaging modalities like Doppler imaging, stress echocardiography, and 3D echocardiography. Transthoracic and transesophageal echocardiography are the most common types of echocardiography. Transthoracic echocardiography uses a transducer placed on the chest to produce images, while transesophageal echocardiography requires a transducer inserted into the esophagus.

Further, echocardiography plays a crucial role in diagnosing and monitoring conditions like blood clots, uncontrolled hypertension, and vaccination response in patients with cardiovascular diseases. Major players in the echocardiography market focus on product innovation and efficiency, with companies like Clarius Mobile Health offering portable, handheld ultrasound devices, and GE Healthcare launching the Vivid Ultra Edition for advanced cardiovascular imaging. The Heart Center Leipzig is also contributing to measurement uniformity and improving patient outcomes through research and development.

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch